Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Higher early lead exposure is linked to delayed puberty in girls.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

Breast cancer patients often worry, lose weight, and cope by praying, meditating, or seeking support.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride can cause enlarged breasts.